All listings for this product
Best-selling in Fiction Books
Save on Fiction Books
- AU $30.61Trending at AU $31.89
- AU $79.95Trending at AU $84.92
- AU $29.93Trending at AU $31.44
- AU $46.03Trending at AU $52.81
- AU $12.75Trending at AU $13.19
- AU $19.76Trending at AU $20.49
- AU $17.27Trending at AU $24.67
About this product
- DescriptionThe infection wasn't supposed to happen, but it did. The treatment was supposed to take care of it, but it didn't. Then Dr. Josh Pearson discovers why his patients, including the former President of the United States, have been dosed with a different strain of the original virus, one that is universally fatal. The only chance for survival is treatment with an experimental drug, but the manufacturer might already have discarded its supply. As if treating the President of the United States isn't stressful eugh, the situation goes from bad to worse when Rachel Moore, a nurse Josh is falling in love with, falls ill. With the nation's eyes on him, Josh must pull off a miracle to save a man who holds a good deal of power and the woman who holds his heart.
- Author BiographyDr. Richard Mabry is a retired physician who writes medical suspense with heart. His novels have won multiple awards: a semifinalist for International Thriller Writers' debut novel; finalists for the Carol Award, Inspirational Reader's Choice Award, and Romantic Times' Reader's Choice Award; and both finalist and winner of the Selah Award. Miracle Drug is his ninth published novel. He and his wife live in Frisco, Texas. You can follow Richard online at RMabry.com, as well as on Twitter (@RichardMabry), and Facebook at RMabryBooks.
- Author(s)Richard L. Mabry
- PublisherUnited Methodist Publishing House
- Date of Publication15/09/2015
- SubjectCrime, Thriller & Adventure
- Place of PublicationNashville
- Country of PublicationUnited States
- ImprintUnited Methodist Publishing House
- Content Noteblack & white illustrations
- Weight340 g
- Width140 mm
- Height216 mm
- Spine20 mm
This item doesn't belong on this page.
Thanks, we'll look into this.